Pharmaceutical Strategy Analysis l Report Store l Pharma Intelligence

Pharma-Payer Partnerships in Emerging Markets

Payer partnerships are becoming widespread as emerging markets become wealthier, but access challenges remain. Partnerships with proven success include “strategic philanthropy,” patient access programs, tiered pricing, and service support models.

Strategy analysis

Pharma-Payer Partnerships in Emerging Markets

Trends in CNS Dealmaking, 2012–16

Biosimilars in Emerging Markets

Gene Editing: The Next Breakthrough in Regenerative Medicine

From R&D Investment to Externalization: Where is the Pharma Industry Maximizing Value?

The Evolution of Pharmaceutical Sales Strategies Continues

US Specialty Drug Market Access

Hemophilia Pricing, Reimbursement, and Access

Acute Myeloid Leukemia Pricing, Reimbursement, and Access

Orphan Drug Access and Pricing in Emerging Markets

Biosimilars Market Access in the EU

Latest Trends in Orphan Drug Pricing and Reimbursement

Gene Therapy Deal-Making Trends, 2012–17

Ovarian Cancer Pricing, Reimbursement, and Access

Crohn’s Disease and Ulcerative Colitis Pricing, Reimbursement, and Access